ES2308850T3 - Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. - Google Patents

Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. Download PDF

Info

Publication number
ES2308850T3
ES2308850T3 ES99951597T ES99951597T ES2308850T3 ES 2308850 T3 ES2308850 T3 ES 2308850T3 ES 99951597 T ES99951597 T ES 99951597T ES 99951597 T ES99951597 T ES 99951597T ES 2308850 T3 ES2308850 T3 ES 2308850T3
Authority
ES
Spain
Prior art keywords
mamiferos
langerhans
antigens
antibodies
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99951597T
Other languages
English (en)
Inventor
Valerie Duvert-Frances
Jean-Jacques Pin
Jenny Valladeau
Valerie Clair
Sem Sealand
Serge J E Lebecque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98402374A external-priority patent/EP0999221A1/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2308850T3 publication Critical patent/ES2308850T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un polipéptido antigénico, que comprende la secuencia de aminoácidos de la SEQ ID NO: 2 o fragmentos de por lo menos 10 residuos contiguos de la misma que tienen la misma función.
ES99951597T 1998-09-25 1999-09-23 Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. Expired - Lifetime ES2308850T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98402374A EP0999221A1 (en) 1998-09-25 1998-09-25 Antibodies to a mammalian Langerhans cell antigen and their uses
EP99400394A EP0997476A3 (en) 1998-09-25 1999-02-18 Antibodies to a mammalian Langerhans cell antigen and their uses
PCT/US1999/022269 WO2000018803A2 (en) 1998-09-25 1999-09-23 Antibodies to mammalian langerhans cell antigen and their uses
EP99951597A EP1115746B1 (en) 1998-09-25 1999-09-23 Antibodies to mammalian langerhans cell antigen and their uses

Publications (1)

Publication Number Publication Date
ES2308850T3 true ES2308850T3 (es) 2008-12-01

Family

ID=26151700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99951597T Expired - Lifetime ES2308850T3 (es) 1998-09-25 1999-09-23 Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.

Country Status (13)

Country Link
EP (3) EP0997476A3 (es)
JP (2) JP4482235B2 (es)
AR (1) AR023904A1 (es)
AT (1) ATE398634T1 (es)
AU (1) AU6400999A (es)
CA (1) CA2344766A1 (es)
CY (1) CY1108288T1 (es)
DE (1) DE69938930D1 (es)
DK (1) DK1115746T3 (es)
ES (1) ES2308850T3 (es)
PT (1) PT1115746E (es)
SI (1) SI1115746T1 (es)
WO (1) WO2000018803A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
AU6138301A (en) 2000-05-08 2001-11-20 Medarex Inc Human monoclonal antibodies to dendritic cells
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
CA2421303A1 (en) * 2000-09-13 2002-03-21 Smithkline Beecham Corporation Novel compounds
WO2003093415A2 (en) * 2002-05-02 2003-11-13 Schering Corporation Methods useful in treatment and prevention of hiv infection
AU2004213749B2 (en) 2003-01-31 2010-02-25 Celldex Therapeutics, Inc. Antibody vaccine conjugates and uses therefor
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
EP2224954B1 (en) 2007-11-07 2014-01-08 Celldex Therapeutics, Inc. Antibodies that bind human dendritic and epithelial cell 205 (dec-205)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery

Also Published As

Publication number Publication date
EP1983001A2 (en) 2008-10-22
CA2344766A1 (en) 2000-04-06
EP0997476A3 (en) 2000-07-19
PT1115746E (pt) 2008-09-10
EP1115746A2 (en) 2001-07-18
EP1115746B1 (en) 2008-06-18
SI1115746T1 (sl) 2008-10-31
JP2009280620A (ja) 2009-12-03
JP2002525103A (ja) 2002-08-13
CY1108288T1 (el) 2014-02-12
DE69938930D1 (de) 2008-07-31
AU6400999A (en) 2000-04-17
EP0997476A2 (en) 2000-05-03
WO2000018803A2 (en) 2000-04-06
AR023904A1 (es) 2002-09-04
JP4482235B2 (ja) 2010-06-16
ATE398634T1 (de) 2008-07-15
WO2000018803A3 (en) 2000-08-31
DK1115746T3 (da) 2008-10-06

Similar Documents

Publication Publication Date Title
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
BR9710968A (pt) Antìgenos de célula b humana; reagentes correlatos
WO1995029193A3 (en) Melanoma antigens
NO973250L (no) Preparater for avlevering av antigener
ES2046462T3 (es) Marcadores de activacion de celulas "t".
EP2311952A3 (en) Antibodies to MRT-1 protein or fragments thereof
DK0941478T3 (da) Assaymetode for peptidspecifikke T-celler
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
DK0759944T3 (da) Forbedringer af og relateret til peptidfremføring
BR9708220A (pt) Peptìdios de ligação hla-a2.1 e seus usos
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR9809656A (pt) Composição imunopotencializante
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
BR9709958A (pt) Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
WO1999049038A3 (en) Human calcium-binding proteins
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
EP0293827A3 (en) Assay for leishmaniasis
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien